NCT00766844

Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm

Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Using MTS Trial System 3510

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Konstantin V. Slavin · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The study investigates safety, feasibility and effectiveness of cervical spinal cord stimulation (SCS) in prevention of cerebral arterial vasospasm following aneurysmal subarachnoid hemorrhage (aSAH). It is postulated that 2 week long stimulation of the cervical spinal cord using an implanted epidural electrode will prevent or decrease severity of cerebral arterial vasospasm following aSAH.

Detailed description

Continuous stimulation of the cervical spinal cord for 14 days after electrode implantation (within 3 days after aneurysmal subarachnoid hemorrhage). The single-arm single-institution non-randomized prospective study evaluates effects of cervical spinal cord stimulation on prevention of cerebral arterial vasospasm. The patients are followed for 12 months after completion of stimulation.

Conditions

• Aneurysmal Subarachnoid Hemorrhage

Interventions

Type	Name	Description
DEVICE	spinal cord stimulation	electrode is inserted into cervical epidural space for continuous spinal cord stimulation

Timeline

• Start date: 2008-04-01
• Primary completion: 2008-11-01
• Completion: 2009-11-01
• First posted: 2008-10-06
• Last updated: 2013-01-23

Locations

1 site across 1 country: United States